Study Evaluating Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
Condition(s):Head-and-neck Squamous Cell CarcinomaLast Updated:March 4, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Head-and-neck Squamous Cell CarcinomaLast Updated:March 4, 2024Not yet recruiting
Condition(s):Head and Neck CancerLast Updated:December 22, 2023Recruiting
Condition(s):Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Squamous Cell Carcinoma; Stage IV Cutaneous Squamous Cell Carcinoma of the Head and NeckLast Updated:July 17, 2023Recruiting
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:December 18, 2023Recruiting
Condition(s):Colorectal CancerLast Updated:November 27, 2023Recruiting
Condition(s):Lung Carcinoma; Metastatic Malignant Neoplasm in the Lung; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8Last Updated:February 6, 2024Recruiting
Condition(s):Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Squamous Cell CarcinomaLast Updated:February 6, 2024Recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:April 6, 2022Recruiting
Condition(s):Malignant Brain Neoplasm; Malignant GliomaLast Updated:November 24, 2023Recruiting
Condition(s):Colorectal Cancer; Pancreatic Ductal Cancer; Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal CancersLast Updated:March 22, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.